Cargando…

Costs, outcomes and challenges for diabetes care in Spain

BACKGROUND: Diabetes is becoming of increasing concern in Spain due to rising incidence and prevalence, although little information is known with regards to costs and outcomes. The information on cost of diabetes in Spain is fragmented and outdated. Our objective is to update diabetes costs, and to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lopez-Bastida, Julio, Boronat, Mauro, Moreno, Juan Oliva, Schurer, Willemien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658938/ https://www.ncbi.nlm.nih.gov/pubmed/23635075 http://dx.doi.org/10.1186/1744-8603-9-17

Ejemplares similares

The economic costs and health-related quality of life of people with HIV/AIDS in the Canary Islands, Spain
por: Lopez-Bastida, Julio, et al.
Publicado: (2009)

Social/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain
por: López-Bastida, Julio, et al.
Publicado: (2017)

Social and economic costs and health-related quality of life in stroke survivors in the Canary Islands, Spain
por: Lopez-Bastida, Julio, et al.
Publicado: (2012)

Assessing the Effect of Including Social Costs in Economic Evaluations of Diabetes-Related Interventions: A Systematic Review
por: Rodriguez-Sanchez, Beatriz, et al.
Publicado: (2021)

Shadow and extended shadow cost sharing associated to informal long-term care: the case of Spain
por: Del Pozo-Rubio, Raúl, et al.
Publicado: (2020)

Health related quality of life of Canary Island citizens
por: Oliva-Moreno, Juan, et al.
Publicado: (2010)

Cost, outcomes, treatment pathways and challenges for diabetes care in Italy
por: Grimaccia, Federico, et al.
Publicado: (2014)

Economic valuation of informal care in cerebrovascular accident survivors in Spain
por: Oliva-Moreno, Juan, et al.
Publicado: (2013)

How relevant are social costs in economic evaluations? The case of Alzheimer’s disease
por: Peña-Longobardo, L. M., et al.
Publicado: (2019)

Correction to: How relevant are social costs in economic evaluations? The case of Alzheimer’s disease
por: Peña-Longobardo, L. M., et al.
Publicado: (2021)

Morbidity, outcomes and cost-benefit analysis of wildlife rehabilitation in Catalonia (Spain)
por: Molina-López, Rafael Angel, et al.
Publicado: (2017)

Socioeconomic costs and health-related quality of life in juvenile idiopathic arthritis: a cost-of-illness study in the United Kingdom
por: Angelis, Aris, et al.
Publicado: (2016)

High levels of lipoprotein(a) are associated with a lower prevalence of diabetes with advancing age: Results of a cross-sectional epidemiological survey in Gran Canaria, Spain
por: Boronat, Mauro, et al.
Publicado: (2012)

The economic burden of disease of epithelial ovarian cancer in Spain: the OvarCost study
por: Delgado-Ortega, Laura, et al.
Publicado: (2018)

Diabetes in Mexico: cost and management of diabetes and its complications and challenges for health policy
por: Barquera, Simon, et al.
Publicado: (2013)

Does the inclusion of societal costs change the economic evaluations recommendations? A systematic review for multiple sclerosis disease
por: Rodríguez-Sánchez, B., et al.
Publicado: (2022)

Cost of Disorders of the Brain in Spain
por: Parés-Badell, Oleguer, et al.
Publicado: (2014)

Response to Comment on: Boronat et al. Differences in Cardiovascular Risk Profile of Diabetic Subjects Discordantly Classified by Diagnostic Criteria Based on Glycated Hemoglobin and Oral Glucose Tolerance Test. Diabetes Care 2010;33:2671–2673
por: Boronat, Mauro, et al.
Publicado: (2011)

Differences in labour participation between people living with HIV and the general population: Results from Spain along the business cycle
por: Peña Longobardo, Luz María, et al.
Publicado: (2018)

Outcomes measured by mortality rates, quality of life and degree of autonomy in the first year in stroke units in Spain
por: Mar, Javier, et al.
Publicado: (2015)

Expert Panel Consensus for Addressing Anti-VEGF Treatment Challenges of Diabetic Macular Edema in Spain
por: Fernández-Vigo, José Ignacio, et al.
Publicado: (2022)

Evidence, Mechanism and Alternative Chemical Seedbank-Level Control of Glyphosate Resistance of a Rigid Ryegrass (Lolium rigidum) Biotype from Southern Spain
por: Fernández-Moreno, Pablo T., et al.
Publicado: (2017)

The Economic Impact and Health-Related Quality of Life of Spinal Muscular Atrophy. An Analysis across Europe
por: Peña-Longobardo, Luz María, et al.
Publicado: (2020)

Cost of Severe Hypoglycemia and Budget Impact with Nasal Glucagon in Patients with Diabetes in Spain
por: Osumili, Beatrice, et al.
Publicado: (2022)

Good practice regarding smoking cessation management in Spain: Challenges and opportunities for primary care physicians and nurses
por: Martin-Cantera, Carlos, et al.
Publicado: (2020)

Cost of early-stage mycosis fungoides treatments in Spain
por: Ortiz-Romero, Pablo Luis, et al.
Publicado: (2020)

Cost-effectiveness analysis of azacitidine in the treatment of high-risk myelodysplastic syndromes in Spain
por: Crespo, Carlos, et al.
Publicado: (2013)

Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom
por: Angelis, Aris, et al.
Publicado: (2015)

The Burden of Spinal Muscular Atrophy on Informal Caregivers
por: Aranda-Reneo, Isaac, et al.
Publicado: (2020)

Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe
por: Angelis, Aris, et al.
Publicado: (2016)

Economic burden of Cardiac Arrest in Spain: analyzing healthcare costs drivers and treatment strategies cost-effectiveness
por: Matilla-García, Mariano, et al.
Publicado: (2023)

Diabetes in Argentina: cost and management of diabetes and its complications and challenges for health policy
por: Caporale, Joaquín E, et al.
Publicado: (2013)

The Usability of ICTs in People with Visual Disabilities: A Challenge in Spain
por: Fuentes, Fiorella, et al.
Publicado: (2022)

Estimating the epidemiological impact and cost-effectiveness profile of a nonavalent HPV vaccine in Spain
por: De La Fuente, Jesús, et al.
Publicado: (2019)

The association between asthma control, health care costs, and quality of life in France and Spain
por: Doz, Marianne, et al.
Publicado: (2013)

Sensors: New Challenges in Spain
por: Pajares, Gonzalo
Publicado: (2010)

Costs of the management of hemophilia A with inhibitors in Spain
por: Bonanad, Santiago, et al.
Publicado: (2021)

Hospital productivity bias when not adjusting for cost heterogeneity: The case of Spain
por: Arvelo-Martín, Alejandro, et al.
Publicado: (2019)

Sick Leave and Costs in Active Workers with Chronic Osteoarthritis Pain in Spain: Outcomes of the OPIOIDS Real World Study
por: Sicras-Mainar, Antoni, et al.
Publicado: (2022)

Considering the societal perspective in economic evaluations: a systematic review in the case of depression
por: Duevel, Juliane Andrea, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e2595ihu469b1cuok2n4i076fq